- Category
- Small (2020-21)
- Udyam number
- UDYAM-WB-10-0006902

Duckbill Drugs Pvt Ltd
About Duckbill Drugs Pvt Ltd
Data last updated:
Duckbill Drugs Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 May 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB1994PTC063258. Its GSTIN is 19AABCD3045J1ZP (West Bengal).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹87 Lakh. It is led by directors including Asoke Kumar Paul and Reeta Paul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.2 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹80.56 Lakh (net margin 11.2%) and EBITDA of ₹1.16 Cr (EBITDA margin 16.1%). Revenue has grown at a compounded annual rate (CAGR) of 3% over five years.
The company has about 56 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Duckbill Drugs. As per MCA filings, the company has satisfied charges of ₹8.15 Cr on record. Court records list 23 cases involving the company, including 10 filed by the company and 13 filed against it; 8 cases are pending.
Duckbill Drugs Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0006902). The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Duckbill Drugs
Contact details
Duckbill Drugs Pvt Ltd's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address7 Kali Prasanna Chatterjee Lane, Ground Floor, Kolkata, West Bengal, India – 700034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Duckbill Drugs Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Duckbill Drugs operates one associated brand: Duckbill Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical products and distributes across Eastern India for healthcare needs. | duckbilldrugs.com |
Business activity
The main business activity of Duckbill Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Duckbill Drugs Pvt Ltd, buy the company report.
Financials of Duckbill Drugs Pvt Ltd
FY 2025 filings availableDuckbill Drugs Pvt Ltd reported revenue of ₹7.2 Cr (up 334% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 334% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹80.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.1% | ||||
| Net Profit Margin | 11.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Duckbill Drugs Pvt Ltd, buy the company report.
Board of directors of Duckbill Drugs Pvt Ltd
Duckbill Drugs has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asoke Kumar Paul | Director | 30 Mar 2023 | 3 Years 7 Months | Current |
| Reeta Paul | Director | 30 Mar 2023 | 3 Years 7 Months | Current |
| Sangita Paul | Director | 30 Mar 2023 | 3 Years 7 Months | Current |
| Tapan Paul | Director | 30 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Duckbill Drugs Pvt Ltd is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SKM Pharma Private Limited, | ₹7.26 Cr (FY 2025) | -32.0% | Bangalore, Karnataka, India | |||
| Skybiotech Life Sciences Private Limited | ₹7.25 Cr (FY 2025) | -36.0% | Aurangabad, Maharashtra, India | |||
| Duckbill Drugs Pvt Ltdthis company | ₹7.2 Cr (FY 2025) | ₹80.56 Lakh | 11.2% | 334.0% | 56 | Kolkata, West Bengal, India |
| Serin Formulations Private Limited | ₹7.2 Cr (FY 2025) | -2.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Duckbill Drugs Pvt Ltd, buy the company report.
Auditor
Duckbill Drugs Pvt Ltd is audited by M G S K & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M G S K & ASSOCIATES | FY 2020 | 328275E |
Shareholding
The shareholding of Duckbill Drugs Pvt Ltd is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Duckbill Drugs Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Oct 2011 | 10320594 | State Bank of India | ₹1.88 Cr | Satisfied | |
| 05 Mar 2009 | 10151239 | Punjab National Bank | ₹2.99 Cr | Satisfied | |
| 06 Mar 2006 | 80052054 | The Federal Bank Limited | ₹2.2 Cr | Satisfied | |
| 19 Jul 2003 | 80009272 | State Bank of India | ₹1.08 Cr | Satisfied |
To see the full charge records of Duckbill Drugs Pvt Ltd, buy the company report.
Total charge records: 4 View all charges
Legal cases
Duckbill Drugs Pvt Ltd has 23 court cases on record: 10 filed by Duckbill Drugs, 13 filed against it. 8 cases are pending and 15 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 12 | 3 | 2 |
| District courts | 9 | 8 | 6 |
| Supreme Court | 1 | 1 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Civil suit | Filed by the company against Bell Finvest India Ltd and Anr | Pending |
| District court, South Twenty Four Parganas, West Bengal | Interim or miscellaneous application | Filed against the company by Bell Finvest India Limited | Disposed |
| NCLT, Kolkata | Insolvency matter | Filed against the company by Bell Finvest [India] Limited. | Disposed |
| High Court | Court case (APO) | Filed against the company by Bell Finvest India Limited | Disposed |
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed against the company by Bell Finvest India Ltd. | Disposed |
To see the full case history of Duckbill Drugs Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Duckbill Drugs Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Duckbill Drugs Pvt Ltd has a workforce of 56 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 56 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 |
To see the full employee and EPFO history of Duckbill Drugs Pvt Ltd, buy the company report.
GST
Duckbill Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCD3045J1ZP | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Duckbill Drugs Pvt Ltd, buy the company report.
Recent activity
Duckbill Drugs Pvt Ltd has 12 board changes on record since 2013: 4 appointments and 8 cessations. The latest: Asoke Kumar Paul ceased to be Additional Director on 29 Sep 2023.
12 earlier events are in the company report.
Frequently asked questions
Duckbill Drugs is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 May 1994 (32+ years old) and is registered under CIN U24232WB1994PTC063258.
Duckbill Drugs has 4 current directors:
- Asoke Kumar Paul - Director
- Reeta Paul - Director
- Sangita Paul - Director
- Tapan Paul - Director
The latest financial statements of Duckbill Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Duckbill Drugs is 19AABCD3045J1ZP, registered in West Bengal.
The CIN (Corporate Identification Number) of Duckbill Drugs is U24232WB1994PTC063258. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Duckbill Drugs has 23 court cases on record: 10 filed by the company and 13 filed against it. 8 are pending. Most are in the high courts.
Duckbill Drugs was incorporated on 19 May 1994, making it 32+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Duckbill Drugs by revenue are SKM Pharma Private Limited,, Skybiotech Life Sciences Private Limited, Serin Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Asoke Kumar Paul ceased to be Additional Director on 29 Sep 2023. Reeta Paul ceased to be Additional Director on 29 Sep 2023. Sangita Paul ceased to be Additional Director on 29 Sep 2023. Duckbill Drugs has 12 board changes on record in total.
Yes, Duckbill Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-WB-10-0006902).
The registered office of Duckbill Drugs is at 7 Kali Prasanna Chatterjee Lane, Ground Floor, Kolkata, West Bengal, India – 700034.

